Office of Research & Development |
|
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I21RX003756-01 |
| Title: | The efficacy of β-aminoisobutyric acid myokine to reduce bone loss after spinal cord injury |
| Principal Investigator: | Hesham Tawfeek |
| Location: | Bronx, NY |
| Congressional District Code: | 13 |
| Research Service: | Rehabilitation R&D |
| Project Period: | June 2021 - May 2023 |
| FY 2021 Funding Amount: | $32,578 |
| Total Award Amount (all years): |
$229,600 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Veterans with chronic motor complete spinal cord injury (SCI) invariably have had bone loss and resultant severe sub-lesional osteoporosis and increased fragility fractures. Currently, there is no widely accepted or proven treatment for osteoporosis in non-ambulatory patients with SCI. The efficacy of anti-resorptive agents in the treatment of those with acute SCI has been questioned and ineffective. As a result, there is an urgent need to develop new therapeutic strategies to prevent bone loss... |